Cargando…

Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria

Selective internal radiation therapy (SIRT) is part of the treatment strategy for hepatocellular carcinoma (HCC). Strong clinical data demonstrated the effectiveness of this therapy in HCC with a significant improvement in patient outcomes. Recent studies demonstrated a strong correlation between th...

Descripción completa

Detalles Bibliográficos
Autores principales:	d’Abadie, Philippe, Walrand, Stephan, Lhommel, Renaud, Hesse, Michel, Borbath, Ivan, Jamar, François
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024927/ https://www.ncbi.nlm.nih.gov/pubmed/35448170 http://dx.doi.org/10.3390/curroncol29040196

Ejemplares similares

TCP post-radioembolization and TCP post-EBRT in HCC are similar and can be predicted using the in vitro radiosensitivity
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Microspheres Used in Liver Radioembolization: From Conception to Clinical Effects
por: d’Abadie, Philippe, et al.
Publicado: (2021)

Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters
por: Hesse, Michel, et al.
Publicado: (2021)

Hepatic Arterial Buffer Response in Liver Radioembolization and Potential Use for Improved Cancer Therapy
por: Walrand, Stephan, et al.
Publicado: (2021)

A Theranostic Approach in SIRT: Value of Pre-Therapy Imaging in Treatment Planning
por: d’Abadie, Philippe, et al.
Publicado: (2022)

Optimal Design of Anger Camera for Bremsstrahlung Imaging: Monte Carlo Evaluation
por: Walrand, Stephan, et al.
Publicado: (2014)

Renal and Red Marrow Dosimetry in Peptide Receptor Radionuclide Therapy: 20 Years of History and Ahead
por: Walrand, Stephan, et al.
Publicado: (2021)

Statistical and radiobiological analysis of the so-called thyroid stunning
por: Walrand, Stephan, et al.
Publicado: (2015)

Diagnostic Superiority of Dual-Time Point [(18)F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors
por: d’Abadie, Philippe, et al.
Publicado: (2023)

Vertebral uptake of (99m)Tc-macroaggregated albumin during lung perfusion scanning
por: D’Abadie, Philippe, et al.
Publicado: (2019)

Yttrium-90-labeled microsphere tracking during liver selective internal radiotherapy by bremsstrahlung pinhole SPECT: feasibility study and evaluation in an abdominal phantom
por: Walrand, Stephan, et al.
Publicado: (2011)

Hemoglobin level significantly impacts the tumor cell survival fraction in humans after internal radiotherapy
por: Walrand, Stephan, et al.
Publicado: (2012)

Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database
por: Roelants, Véronique, et al.
Publicado: (2012)

EANM dosimetry committee series on standard operational procedures: a unified methodology for (99m)Tc-MAA pre- and (90)Y peri-therapy dosimetry in liver radioembolization with (90)Y microspheres
por: Chiesa, Carlo, et al.
Publicado: (2021)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

Retrospective SPECT/CT dosimetry following transarterial radioembolization
por: Thompson, Briana C., et al.
Publicado: (2021)

Automatic healthy liver segmentation for holmium-166 radioembolization dosimetry
por: Stella, Martina, et al.
Publicado: (2023)

A global evaluation of advanced dosimetry in transarterial radioembolization of hepatocellular carcinoma with Yttrium-90: the TARGET study
por: Lam, Marnix, et al.
Publicado: (2022)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Simplification of dosimetry in (90)Y-radioembolization therapy by dual planar images
por: Abuqbeitah, Mohammad, et al.
Publicado: (2022)

Radioembolization for the treatment of hepatocellular carcinoma
por: Kim, Hyo-Cheol
Publicado: (2017)

Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with (188)Re
por: De La Vega, José Carlos, et al.
Publicado: (2019)

Inter-observer variability of (90)Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization
por: Meyers, Nicolas, et al.
Publicado: (2020)

Significant artefactual noise in (90)Y TOF-PET imaging of low specific activity phantoms arises despite increased acquisition time
por: Hesse, Michel, et al.
Publicado: (2019)

Choi criteria are superior in evaluating tumor response in patients treated with transarterial radioembolization for hepatocellular carcinoma
por: WENG, ZHIHONG, et al.
Publicado: (2013)

Direct comparison and reproducibility of two segmentation methods for multicompartment dosimetry: round robin study on radioembolization treatment planning in hepatocellular carcinoma
por: Lam, Marnix, et al.
Publicado: (2023)

Phantom validation of quantitative Y-90 PET/CT-based dosimetry in liver radioembolization
por: D’Arienzo, Marco, et al.
Publicado: (2017)

Fast technetium‐99m liver SPECT for evaluation of the pretreatment procedure for radioembolization dosimetry
por: van der Velden, Sandra, et al.
Publicado: (2018)

Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report
por: Baikovitz, Jacqueline B, et al.
Publicado: (2021)

Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner
por: Linder, Pia M., et al.
Publicado: (2023)

Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization
por: Lopez, Benjamin P., et al.
Publicado: (2022)

Radioembolization for Hepatocellular Carcinoma using TheraSphere(®)
por: Ali, Safiyya Mohamed
Publicado: (2011)

Transarterial radioembolization for hepatocellular carcinoma: a review
por: Sacco, Rodolfo, et al.
Publicado: (2016)

Radioembolization Followed by Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Vardar, Baran U, et al.
Publicado: (2022)

The Role of Quantitative and Semi-quantitative [(18)F]FDG-PET/CT Indices for Evaluating Disease Activity and Management of Patients With Dermatomyositis and Polymyositis
por: Yildiz, Halil, et al.
Publicado: (2022)

Selection Criteria for Determination of Optimal Reconstruction Method for Cu-64 Trastuzumab Dosimetry on Siemens Inveon PET Scanner
por: Lee, Seonhwa, et al.
Publicado: (2019)

Impact of (90)Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization
por: Mikell, Justin K., et al.
Publicado: (2018)

Hepatobiliary Scintigraphy and Glass (90)Y Radioembolization with Personalized Dosimetry: Dynamic Changes in Treated and Nontreated Liver
por: Allimant, Carole, et al.
Publicado: (2021)

Erratum: “Factors modulating (99m)Tc‐MAA planar lung dosimetry for (90)Y radioembolization”
Publicado: (2023)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ode7f2kjo1n8ikm7colahvnd4n